| Literature DB >> 28483413 |
Michael Weller1, Martin van den Bent2, Jörg C Tonn3, Roger Stupp4, Matthias Preusser5, Elizabeth Cohen-Jonathan-Moyal6, Roger Henriksson7, Emilie Le Rhun8, Carmen Balana9, Olivier Chinot10, Martin Bendszus11, Jaap C Reijneveld12, Frederick Dhermain13, Pim French14, Christine Marosi5, Colin Watts15, Ingela Oberg16, Geoffrey Pilkington17, Brigitta G Baumert18, Martin J B Taphoorn19, Monika Hegi20, Manfred Westphal21, Guido Reifenberger22, Riccardo Soffietti23, Wolfgang Wick24.
Abstract
The European Association for Neuro-Oncology guideline provides recommendations for the clinical care of adult patients with astrocytic and oligodendroglial gliomas, including glioblastomas. The guideline is based on the 2016 WHO classification of tumours of the central nervous system and on scientific developments since the 2014 guideline. The recommendations focus on pathological and radiological diagnostics, and the main treatment modalities of surgery, radiotherapy, and pharmacotherapy. In this guideline we have also integrated the results from contemporary clinical trials that have changed clinical practice. The guideline aims to provide guidance for diagnostic and management decisions, while limiting unnecessary treatments and costs. The recommendations are a resource for professionals involved in the management of patients with glioma, for patients and caregivers, and for health-care providers in Europe. The implementation of this guideline requires multidisciplinary structures of care, and defined processes of diagnosis and treatment.Entities:
Mesh：
Substances：
Year: 2017 PMID： 28483413 DOI： 10.1016/S1470-2045(17)30194-8
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316